Neuroprotective effects of statins against amyloid β-induced neurotoxicity
A growing body of evidence suggests that disruption of the homeostasis of lipid metabolism affects the pathogenesis of Alzheimer's disease (AD). In particular, dysregulation of cholesterol homeostasis in the brain has been reported to considerably increase the risk of developing AD. Thus, dysre...
Main Authors: | Hsin-Hua Li, Chih-Li Lin, Chien-Ning Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=2;spage=198;epage=206;aulast=Li |
Similar Items
-
Aβ-40 Y10F Increases βfibrils Formation but Attenuates the Neurotoxicity of Amyloid-β Peptide
by: Zhaofeng Jiang, et al.
Published: (2012-04-01) -
Amyloid-β Protofibril Formation and Neurotoxicity : Implications for Alzheimer’s Disease
by: Johansson, Ann-Sofi
Published: (2007) -
Ketamine: Neuroprotective or Neurotoxic?
by: Divya Choudhury, et al.
Published: (2021-09-01) -
Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity
by: Xueling Dai, et al.
Published: (2015-05-01) -
The Neuroprotection of KIBRA in Promoting Neuron Survival and Against Amyloid β-Induced Apoptosis
by: Lin Song, et al.
Published: (2019-04-01)